Expression profiling of response to BET inhibition in agressive  B-Cell lymphoma cell lines
We studied  response to JQ1, a BET inhibitor, on gene expression profiles for 10 B-cell lymphoma cell line Overall design: Cells cere treated for 24h with 500 nM JQ1 and compared to DMS0-treated counterparts.